Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy
Clinical Pharmacology: Advances and Applications | Aug 15, 2017
Clinical Pharmacology: Advances and Applications | Aug 15, 2017